Publicacións nas que colabora con Francisco Campos Pérez (86)

2024

  1. New Perspectives in Neuroprotection for Ischemic Stroke

    Neuroscience

  2. Pharmacological preclinical comparison of tenecteplase and alteplase for the treatment of acute stroke

    Journal of Cerebral Blood Flow and Metabolism

  3. Systemic biomarker associated with poor outcome after futile reperfusion

    European Journal of Clinical Investigation, Vol. 54, Núm. 6

  4. Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke

    Journal of Nanobiotechnology, Vol. 22, Núm. 1

2023

  1. Influence of Temperature Chronobiology on Stroke Outcome

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  2. Periodontitis is associated with subclinical cerebral and carotid atherosclerosis in hypertensive patients: A cross-sectional study

    Clinical Oral Investigations, Vol. 27, Núm. 7, pp. 3489-3498

2022

  1. Antihyperthermic Treatment in the Management of Malignant Infarction of the Middle Cerebral Artery

    Journal of Clinical Medicine, Vol. 11, Núm. 10

  2. Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  3. Fibrin-Targeted Nanoparticles for Finding, Visualizing and Characterizing Blood Clots in Acute Ischemic Stroke

    Pharmaceutics, Vol. 14, Núm. 10

  4. Multi-Ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke

    Brain, Vol. 145, Núm. 7, pp. 2394-2406

  5. Neurological Instability in Ischemic Stroke: Relation with Outcome, Latency Time, and Molecular Markers

    Translational Stroke Research, Vol. 13, Núm. 2, pp. 228-237

  6. New Perspectives for Developing Therapeutic Bioconjugates of Metabolite-Depleting Enzymes: Lessons Learned Combating Glutamate Excitotoxicity

    Biomacromolecules

  7. Stress Granules and Acute Ischemic Stroke: Beyond mRNA Translation

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

  8. Surrogate biomarkers of outcome for wake-up ischemic stroke

    BMC Neurology, Vol. 22, Núm. 1

  9. The Smoking Paradox in Stroke Patients Under Reperfusion Treatment Is Associated With Endothelial Dysfunction

    Frontiers in Neurology, Vol. 13

  10. sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy

    Annals of Clinical and Translational Neurology, Vol. 9, Núm. 2, pp. 171-180

2021

  1. Article targeting pro-oxidant iron with deferoxamine as a treatment for ischemic stroke: Safety and optimal dose selection in a randomized clinical trial

    Antioxidants, Vol. 10, Núm. 8

  2. Characterization of a temporal profile of biomarkers as an index for ischemic stroke onset definition

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  3. Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome

    Stroke, Vol. 52, Núm. 1, pp. 132-141

  4. Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage

    Translational Research, Vol. 230, pp. 68-81